Categories | New-onset SLE | Re-visiting SLE |
---|---|---|
N | 16 | 34 |
Females, n (%) | 15 (93.8) | 31 (91.4) |
Age, mean (SD), years | 28.1 (11.1) | 38.2 (14.6) |
ANA (+, ≥1:100), n (%) | 16 (100) | 33 (97.1) |
Anti-dsDNA, mean (SD), IU/mL | 346.6 (329.3)* | 165.3 (267.7) |
IgG, mean (SD), g/L | 19.1 (5.9) | 17.0 (9.6) |
C3, mean (SD), g/L | 0.52 (0.33) | 0.63 (0.23) |
C4, mean (SD), g/L | 0.09 (0.060)* | 0.16 (0.050) |
ESR, mean (SD), mm/h | 62.1 (41.2)* | 35.1 (38.0) |
SLEDAI score, mean (SD) | 8.4 (5.0) | 5.5 (4.8) |
Lymphocytes, mean (SD), %a | 17.1 (1.0) | 16.8 (7.9) |
CD3+ lymphocytes, mean (SD), %b | 68.3 (11.0) | 70.3 (9.9) |
CD4+ T subset, mean (SD), %c | 40.8 (5.4) | 47.8 (14.9) |
CD4+ T subset, mean (SD), /mL | 269.5 (8.7) | 330.1 (239.4) |
CD8+ T subset, mean (SD), %c | 59.2 (5.4) | 52.2 (14.9) |
CD8+ T subset, mean (SD), /mL | 435.8 (97.5) | 455.1 (77.1) |
Ratio of CD4+/CD8+T, mean (SD) | 1.02 (0.85) | 1.03 (0.64) |